{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:29:55Z","timestamp":1649118595973},"reference-count":29,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2021,1,1]]},"DOI":"10.1248\/bpb.b20-00596","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T22:12:59Z","timestamp":1609452779000},"page":"63-68","source":"Crossref","is-referenced-by-count":0,"title":["Potential Estrogenic Properties of 17\u03b2-Hydroxy-ethylimine Estradiol Derivative Targeted to Menopause Stage"],"prefix":"10.1248","volume":"44","author":[{"given":"Guadalupe Luisa","family":"Jimenez-S\u00e1nchez","sequence":"first","affiliation":[{"name":"Departament of Pharmacology, National Autonomous University of Mexico. Av. Universidad No. 3000, Ciudad Universitaria, Colonia Copilco Universidad"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Segovia-Mendoza","sequence":"additional","affiliation":[{"name":"Departament of Pharmacology, National Autonomous University of Mexico. Av. Universidad No. 3000, Ciudad Universitaria, Colonia Copilco Universidad"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Figueroa","sequence":"additional","affiliation":[{"name":"Departament of Pharmacology, National Autonomous University of Mexico. Av. Universidad No. 3000, Ciudad Universitaria, Colonia Copilco Universidad"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Lemini","sequence":"additional","affiliation":[{"name":"Departament of Pharmacology, National Autonomous University of Mexico. Av. Universidad No. 3000, Ciudad Universitaria, Colonia Copilco Universidad"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Parry BL. Perimenopausal depression. <i>Am. J. Psychiatry<\/i>, <b>165<\/b>, 23\u201327 (2008).","DOI":"10.1176\/appi.ajp.2007.07071152"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) S\u00e1nchez-Rodr\u00edguez MA, Castrejon-Delgado L, Zacarias-Flores M, Arronte-Rosales A, Mendoza-Nunez VM. Quality of life among post-menopausal women due to oxidative stress boosted by dysthymia and anxiety. <i>BMC Womens Health<\/i>, <b>17<\/b>, 1 (2017).","DOI":"10.1186\/s12905-016-0358-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kaunitz AM, Manson JE. Management of Menopausal Symptoms. <i>Obstet. Gynecol.<\/i>, <b>126<\/b>, 859\u2013876 (2015).","DOI":"10.1097\/AOG.0000000000001058"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ma H, Chung MH, Lu Y, Nishihara T, Hattori M. Estrogenic effects of the herbal formula, menoprogen, in ovariectomized rats. <i>Biol. Pharm. Bull.<\/i>, <b>33<\/b>, 455\u2013460 (2010).","DOI":"10.1248\/bpb.33.455"},{"key":"5","unstructured":"5) Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. <i>BMJ<\/i>, <b>364<\/b>, k4810 (2019)."},{"key":"6","unstructured":"6) Perkins MS, Louw-du Toit R, Africander D. Hormone therapy and breast cancer: emerging steroid receptor mechanisms. <i>J. Mol. Endocrinol.<\/i>, <b>61<\/b>, R133\u2013R160 (2018)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Lemini C, Rubio-Poo C, Silva G, Garcia-Mondragon J, Zavala E, Mendoza-Patino N, Castro D, Cruz-Almanza R, Mandoki JJ. Anticoagulant and estrogenic effects of two new 17 beta-aminoestrogens, butolame [17 beta-(4-hydroxy-1-butylamino)-1,3,5(10)-estratrien-3-ol] and pentolame [17\u03b2-(5-hydroxy-1-pentylamino)-1,3,5(10)-estratrien-3-ol]. <i>Steroids<\/i>, <b>58<\/b>, 457\u2013461 (1993).","DOI":"10.1016\/0039-128X(93)90002-5"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Lemini C, Cruz-Lopez B, Mart\u00ednez-Mota L. Participation of estrogen receptors in the antidepressant-like effect of prolame on the forced swimming test. <i>Pharmacol. Biochem. Behav.<\/i>, <b>103<\/b>, 659\u2013665 (2013).","DOI":"10.1016\/j.pbb.2012.11.004"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Irmscher K. Die umsetzung von steroidketonen mit aminoalkoholen. <i>Chem. Ber.<\/i>, <b>95<\/b>, 907\u2013917 (1962).","DOI":"10.1002\/cber.19620950415"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Takikawa H. Anti-uterotropic activities of 16beta-ethyl-1,3,5(10)-estratrien-3,17beta-diol(16beta-ethylestradiol-17beta) and related compounds. <i>Chem. Pharm. Bull.<\/i>, <b>25<\/b>, 501\u2013503 (1977).","DOI":"10.1248\/cpb.25.501"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lemini C, Canchola E. Effects of 17beta-aminoestrogens on the sexual behavior of female rats. <i>Physiol. Behav.<\/i>, <b>96<\/b>, 662\u2013666 (2009).","DOI":"10.1016\/j.physbeh.2009.01.003"},{"key":"12","unstructured":"12) Pellow S, File SE. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. <i>Pharmacol. Biochem. Behav.<\/i>, <b>24<\/b>, 525\u2013529 (1986)."},{"key":"13","unstructured":"13) Odum J, Lefevre PA, Tittensor S, Paton D, Routledge EJ, Beresford NA, Sumpter JP, Ashby J. The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. <i>Regul. Toxicol. Pharmacol.<\/i>, <b>25<\/b>, 176\u2013188 (1997)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Lemini C, Franco Y, Avila ME, Jaimez R. Estrogenic effects of 17 beta-aminoestrogens assessed in uteri of rats and mice. <i>Eur. J. Pharmacol.<\/i>, <b>510<\/b>, 235\u2013239 (2005).","DOI":"10.1016\/j.ejphar.2005.01.028"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Jaimez R, Cooney A, Jackson K, Lemus AE, Lemini C, Cardenas M, Garcia R, Silva G, Larrea F. <i>In vivo<\/i> estrogen bioactivities and <i>in vitro<\/i> estrogen receptor binding and transcriptional activities of anticoagulant synthetic 17beta-aminoestrogens. <i>J. Steroid Biochem. Mol. Biol.<\/i>, <b>73<\/b>, 59\u201366 (2000).","DOI":"10.1016\/S0960-0760(00)00053-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Baum MJ, Everitt BJ, Herbert J, Keverne EB. Hormonal basis of proceptivity and receptivity in female primates. <i>Arch. Sex. Behav.<\/i>, <b>6<\/b>, 173\u2013192 (1977).","DOI":"10.1007\/BF01541126"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Pfaff DW, Kow LM, Loose MD, Flanagan-Cato LM. Reverse engineering the lordosis behavior circuit. <i>Horm. Behav.<\/i>, <b>54<\/b>, 347\u2013354 (2008).","DOI":"10.1016\/j.yhbeh.2008.03.012"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Micevych PE, Meisel RL. Integrating neural circuits controlling female sexual behavior. <i>Front. Syst. Neurosci.<\/i>, <b>11<\/b>, 42 (2017).","DOI":"10.3389\/fnsys.2017.00042"},{"key":"19","unstructured":"19) Frye CA. Inhibition of 5alpha-reductase enzyme or GABA(A) receptors in the VMH and the VTA attenuates progesterone-induced sexual behavior in rats and hamsters. <i>J. Endocrinol. Invest.<\/i>, <b>24<\/b>, 399\u2013407 (2001)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Wang M. Neurosteroids and GABA-A receptor function. <i>Front. Endocrinol.<\/i> (Lausanne), <b>2<\/b>, 44 (2011).","DOI":"10.3389\/fendo.2011.00044"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Frye CA, Walf AA, Petralia SM. Progestins\u2019 effects on sexual behaviour of female rats and hamsters involving D1 and GABA(A) receptors in the ventral tegmental area may be G-protein-dependent. <i>Behav. Brain Res.<\/i>, <b>172<\/b>, 286\u2013293 (2006).","DOI":"10.1016\/j.bbr.2006.05.014"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Al-Rahbi B, Zakaria R, Othman Z, Hassan A, Muthuraju S, Wan Mohammad WM. Mood and memory function in ovariectomised rats exposed to social instability stress. <i>Biomed. Res. Int.<\/i>, <b>2013<\/b>, 493643 (2013).","DOI":"10.1155\/2013\/493643"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Daendee S, Thongsong B, Kalandakanond-Thongsong S. Effects of time of estrogen deprivation on anxiety-like behavior and GABAA receptor plasticity in ovariectomized rats. <i>Behav. Brain Res.<\/i>, <b>246<\/b>, 86\u201393 (2013).","DOI":"10.1016\/j.bbr.2013.03.008"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Rodr\u00edguez-Landa JF, Cueto-Escobedo J, Puga-Olguin A, Rivadeneyra-Dominguez E, Bernal-Morales B, Herrera-Huerta EV, Santos-Torres A. The phytoestrogen genistein produces similar effects as 17beta-estradiol on anxiety-like behavior in rats at 12 weeks after ovariectomy. <i>Biomed. Res. Int.<\/i>, <b>2017<\/b>, 9073816 (2017).","DOI":"10.1155\/2017\/9073816"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Handley SL, McBlane JW. An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. <i>J. Pharmacol. Toxicol. Methods<\/i>, <b>29<\/b>, 129\u2013138 (1993).","DOI":"10.1016\/1056-8719(93)90063-K"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Walf AA, Frye CA. Anti-anxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic\u2013pituitary\u2013adrenal axis activity. <i>Neuropsychopharmacology<\/i>, <b>30<\/b>, 1288\u20131301 (2005).","DOI":"10.1038\/sj.npp.1300708"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) aan het Rot M, Mathew SJ, Charney DS. Neurobiological mechanisms in major depressive disorder. <i>CMAJ<\/i>, <b>180<\/b>, 305\u2013313 (2009).","DOI":"10.1503\/cmaj.080697"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Amin Z, Canli T, Epperson CN. Effect of estrogen\u2013serotonin interactions on mood and cognition. <i>Behav. Cogn. Neurosci. Rev.<\/i>, <b>4<\/b>, 43\u201358 (2005).","DOI":"10.1177\/1534582305277152"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Osterlund MK, Halldin C, Hurd YL. Effects of chronic 17beta-estradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain. <i>Synapse<\/i>, <b>35<\/b>, 39\u201344 (2000).","DOI":"10.1002\/(SICI)1098-2396(200001)35:1<39::AID-SYN5>3.0.CO;2-T"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/1\/44_b20-00596\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T03:20:02Z","timestamp":1609557602000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/44\/1\/44_b20-00596\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b20-00596","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}